
|Articles|April 1, 2019
- Pharmaceutical Executive-04-01-2019
- Volume 39
- Issue 4
Pharmaceutical Executive, April 2019 Issue (PDF)
Click the title above to open the Pharmaceutical Executive April 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 7 years ago
Biosimilars Name Game Remains Thorny Issuealmost 7 years ago
HBA's Woman of the Year 2019almost 7 years ago
Sharing Your Voicealmost 7 years ago
Health Technology’s Double-Edged Swordalmost 7 years ago
True Grit: Talent Management from the Ground Upalmost 7 years ago
Reinventing Pharma’s Talent Searchalmost 7 years ago
Hiring a Chief Diversity Officeralmost 7 years ago
Are Pharma Marketers Fighting the Last War?almost 7 years ago
Ready Patient Onealmost 7 years ago
Country Report: ChinaNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
J.P. Morgan 2026: Pfizer’s Pivot from Covid to Pipeline Execution
2
JP Morgan 2026: Bristol Myers Squibb Focuses on the Next Decade
3
Johnson & Johnson Announces Second $2 Billion Manufacturing Facility in North Carolina
4
Pharmaceutical Executive Daily: Johnson & Johnson Continues $55 Billion Manufacturing Investment
5




